Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market, By Type (2’FL, 3’FL, 3’SL and 6’SL), Concentration (Neutral, Acidic), Applications (Infant Formulas, Health Ingredients for Human and Animal, Food and Beverages and Food Supplements), Distribution channel (Hypermarkets and Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, Online Sales Channel) – Industry Trends and Forecast to 2030.
Data Bridge Market Research analyses that the human milk oligosaccharides (HMOs) in infant formula market is expected to reach USD 540.12 billion by 2030, which is USD 115.24 billion in 2022, registering a CAGR of 21.30% during the forecast period of 2023 to 2030.
Access Full 350 Pages PDF Report @
https://www.databridgemarketresearch.com/reports/global-human-milk-oligosaccharides-in-infant-formula-market
**Segments**
- **Type**: The HMOs in infant formula market can be segmented based on type into acidic, neutral, and others. Acidic HMOs are known for their ability to inhibit the adhesion of pathogens to epithelial cells in the gut, thus enhancing the immune system of infants. Neutral HMOs, on the other hand, act as prebiotics, promoting the growth of beneficial bacteria in the gut microbiome.
- **Application**: The market can also be segmented based on application into infant formula, food supplements, dietary supplements, and others. Infant formula remains the predominant application segment for HMOs due to their resemblance to human breast milk, offering similar health benefits to infants who are not breastfed.
- **Form**: Furthermore, the market can be segmented based on form into powder and liquid forms. Powdered HMOs are convenient for storage and transportation, while liquid formulations are ideal for immediate consumption and ease of preparation.
**Market Players**
- **DuPont de Nemours, Inc.**: DuPont is a key player in the HMOs in infant formula market, offering a wide range of HMO ingredients for infant nutrition formulations. The company focuses on developing innovative solutions to meet the nutritional needs of infants worldwide.
- **FrieslandCampina**: FrieslandCampina is another prominent player in the market, providing high-quality HMO ingredients for infant formula applications. The company emphasizes the importance of HMOs in promoting gut health and immune function in infants.
- **Glycom A/S**: Glycom A/S is a leading supplier of HMOs for infant nutrition, known for its expertise in carbohydrate chemistry and biotechnology. The company collaborates with researchers and industry partners to advance the understanding of HMO benefits in infant health.
- **Ingredion Incorporated**: Ingredion offers a diverse portfolio of HMO ingredients for infant formula manufacturers, focusing on delivering nutritional solutions that support infant growth and development. The company's researchThe HMOs in infant formula market is witnessing significant growth and evolution driven by the increasing awareness among parents regarding the importance of early nutrition for infant health and development. The segmentation of the market based on type into acidic, neutral, and other HMOs signifies the diverse functionalities that these oligosaccharides offer in promoting infant health. Acidic HMOs play a crucial role in enhancing the immune system of infants by inhibiting pathogen adhesion, while neutral HMOs act as prebiotics to support the growth of beneficial gut bacteria. This segmentation allows manufacturers to target specific health benefits and cater to the varying needs of infants.
In terms of application segmentation, infant formula stands out as the dominant segment for HMOs, reflecting the demand for alternative nutritional sources that mimic the composition of human breast milk. The resemblance of HMOs to breast milk components has positioned them as valuable ingredients in infant formula products, offering benefits such as immune system support and gut health promotion. Additionally, the segmentation based on form into powder and liquid forms caters to the preferences of consumers and manufacturers. Powdered HMOs provide convenience in storage and transportation, while liquid formulations offer ease of preparation and immediate consumption, enhancing the overall user experience.
Key market players such as DuPont de Nemours, Inc., FrieslandCampina, Glycom A/S, and Ingredion Incorporated are driving innovation and growth in the HMOs in infant formula market through their expertise and product offerings. DuPont's focus on developing innovative HMO ingredients aligns with the market demand for advanced infant nutrition solutions. FrieslandCampina's emphasis on promoting gut health and immune function highlights the importance of HMOs in infant health outcomes. Glycom A/S's commitment to collaboration and research underscores the continuous advancement in understanding the benefits of HMOs. Ingredion's diverse portfolio of HMO ingredients positions the company as a reliable partner for infant formula manufacturers seeking nutritional solutions for infant growth and development.
Overall**Segments**
- **Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market, By Type (2’FL, 3’FL, 3’SL and 6’SL), Concentration (Neutral, Acidic), Applications (Infant Formulas, Health Ingredients for Human and Animal, Food and Beverages and Food Supplements), Distribution channel (Hypermarkets and Supermarkets, Drug Store or Pharmacy, Mass Merchandiser, Departmental Stores, Mono-brand Stores, Specialty Stores, Online Sales Channel) – Industry Trends and Forecast to 2030.**
The Global Human Milk Oligosaccharides (HMOs) in Infant Formula Market is witnessing substantial growth and innovation as a result of the growing awareness among parents about the significance of early nutrition for infant health and development. The segmentation based on different types of HMOs such as 2’FL, 3’FL, 3’SL, and 6’SL, along with concentrations like neutral and acidic, highlights the diverse functionalities that these oligosaccharides offer in supporting infant health. This segmentation enables manufacturers to target specific health benefits and cater to the unique needs of infants.
The application segmentation of the market into infant formulas, health ingredients for human and animal consumption, food and beverages, and food supplements illuminates the varied uses of HMOs beyond just infant nutrition. The demand for HMOs in infant formulas is driven by their resemblance to human breast milk
The report provides insights on the following points:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Human Milk Oligosaccharides (HMOs) in Infant Formula Market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Human Milk Oligosaccharides (HMOs) in Infant Formula Market.
Table of Content:
Section 01: Executive Summary
Section 02: Scope of The Report
Section 03: Research Methodology
Section 04: Introduction
Section 05: Market Landscape
Section 06: Market Sizing
Section 07: Five Forces Analysis
Section 08: Market Segmentation by Product
Section 09: Market Segmentation by Application
Section 10: Customer Landscape
Section 11: Market Segmentation by End-User
Section 12: Regional Landscape
Section 13: Decision Framework
Section 14: Drivers and Challenges
Section 15: Market Trends
Section 16: Competitive Landscape
Section 17: Company Profiles
Section 18: Appendix
The following are the regions covered in this report.
- North America [U.S., copyright, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- The Middle East & Africa [GCC, North Africa, South Africa, Rest of the Middle East and Africa]
This study answers to the below key questions:
- What are the key factors driving the Human Milk Oligosaccharides (HMOs) in Infant Formula Market?
- What are the challenges to market growth?
- Who are the key players in the Human Milk Oligosaccharides (HMOs) in Infant Formula Market?
- What are the market opportunities and threats faced by the key players?
Browse Trending Reports:
Brown Rice Syrup Market
Premium Denim Jeans Market
Vitamin a In Feed Additives Market
Subsea Control Systems Market
Deflectable Catheters Market
Building Acoustics Market
Rail Fasteners Market
Alpha Blockers Market
Biopolymer Coatings Market
Durable Medical Equipment Market
Acoustic Vehicle Alerting Systems Market
Cycling Jersey Market
Acromesomelic Dysplasia Market
Disinfection Equipment Market
Cutaneous Mastocytosis Treatment Market
Military Vetronics Market
15 Methylpropylbenzene Isobutyl Benzene Market
Copper Sulphate Market
Thymoquinone Market
Takotsubo Cardiomyopathy Market
Acromicric Dysplasia Treatment Market
Biological Dural Repair Market
Electroencephalogram Eeg Disposable Medical Electrodes Market
Ambient Food Packaging Market
Decompression Toys Market
Gray Foam Glass Market
Light Attack And Reconnaissance Aircraft Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email: [email protected]"